Cart summary

You have no items in your shopping cart.

PD0166285

SKU: orb1223217

Description

PD0166285 is a potent Wee1 inhibitor and Chk1 inhibitor with activity at nanomolar concentrations. This G2 checkpoint abrogation by PD0166285 was demonstrated to kill cancer cells, there at a toxic highest dose of 0.5 muM in some cell lines for exposure periods of no longer than 6 hours. The deregulated cell cycle progression may have ultimately damaged the cancer cells. We herein report one of the mechanism by which PD0166285 leads to cell death in the B16 mouse melanoma cell line.

Images & Validation

Key Properties

CAS Number185039-89-8
MW512.43
Purity>98% (HPLC)
FormulaC26H27Cl2N5O2
SMILESCCN(CC)CCOc1ccc(Nc2nc3c(cn2)cc(c(=O)n3C)c2c(Cl)cccc2Cl)cc1
TargetGPCR19
SolubilityDMSO : 65 mg/mL 126.85 mM; H2O : < 0.1 mg/mL

Bioactivity

In Vivo
Animal model: Wild-type, Abcg2-/-, Abcb1a/b-/-and Abcb1a/b; Abcg2-/-FVB mice. Dosage: 5 mg/kg. Administration: IV. Result: Cmax is about 400 ng/mL. P-gp, but not BCRP, limited the brain penetration of PD0166285.
In Vitro
PD0166285 (0.5 μM) dramatically inhibits irradiation-induced Cdc2 phosphorylation at the Tyr-15 and Thr-14 in seven of seven cancer cell lines. PD0166285 sensitizes radiation-induced cell killing in p53 mutant HT29 cells and in the E6-transfected, p53-null ovarian cancer cell line PA-1 but to a lesser extent in p53 wild-type PA-1 cells. PD0166285 abrogates irradiation-induced G2 arrest and significantly increases mitotic cell populations. PD0166285 acts as a radiosensitizer to sensitize cells to radiation-induced cell death with a sensitivity enhancement ratio of 1.23. Western blot analysis. Cell line: Human and mouse cancer cell lines (HCT116, HT29, DLD-1, HCT8, H460, HeLa, C 26). Concentration: 0.5 μM. Incubation time: 4 h. Result: Inhibited Cdc2Y15 and CdcT14 phosphorylation.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

PD0166285 | PD 0166285 | PD0166285

Similar Products

  • PD0166285 dihydrochloride [orb1685538]

    212391-63-4

    585.35

    C26H29Cl4N5O2

    1 mg
  • PD0166285 [orb1300335]

    99.59% (May vary between batches)

    185039-89-8

    512.43

    C26H27Cl2N5O2

    5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 1 mg, 1 ml x 10 mM (in DMSO)
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

PD0166285 (orb1223217)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

2 mg
$ 130.00
5 mg
$ 200.00
10 mg
$ 300.00
25 mg
$ 620.00
50 mg
$ 900.00
100 mg
$ 1,260.00
500 mg
$ 2,490.00